ShanGe
2021-06-23
Great ariticle, would you like to share it?
After-Hours Stock Movers: (SEAC) (SHAK) (CLNE) Higher; (GMTX) (EYES) (BSY) Lower
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":123907470,"tweetId":"123907470","gmtCreate":1624405674290,"gmtModify":1631888906480,"author":{"id":3582538893691109,"idStr":"3582538893691109","authorId":3582538893691109,"authorIdStr":"3582538893691109","name":"ShanGe","avatar":"https://static.tigerbbs.com/d4a011d6f4f4fea0a80bcb10d98906e0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\nGreat ariticle, would you like to share it?</body></html>","htmlText":"<html><head></head><body>\nGreat ariticle, would you like to share it?</body></html>","text":"Great ariticle, would you like to share it?","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/123907470","repostId":2145066030,"repostType":4,"repost":{"id":"2145066030","kind":"news","pubTimestamp":1624404720,"share":"https://ttm.financial/m/news/2145066030?lang=&edition=full","pubTime":"2021-06-23 07:32","market":"us","language":"en","title":"After-Hours Stock Movers: (SEAC) (SHAK) (CLNE) Higher; (GMTX) (EYES) (BSY) Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2145066030","media":"StreetInsider","summary":"After-Hours Stock Movers:\nGemini Therapeutics, Inc. (Nasdaq: GMTX) 35.7% LOWER; announced initial da","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/GMTX\">Gemini Therapeutics, Inc.</a> (Nasdaq: GMTX) 35.7% LOWER; announced initial data from its Phase 2a ReGAtta study of GEM103 as of May 2021 in patients with geographic atrophy (GA) secondary to dry <a href=\"https://laohu8.com/S/AMD\">AMD</a>. ReGAtta is a dose escalation trial of GEM103, which is intravitreally administered recombinant human complement factor H (CFH), in dry AMD patients. The trial, which remains ongoing, is designed to evaluate safety and tolerability, as well as measures of intraocular pharmacokinetics (PK) and disease-relevant biomarkers, to inform the late-stage development program.</p>\n<p><a href=\"https://laohu8.com/S/EYES\">Second Sight Medical Products</a>, Inc. (NASDAQ: EYES) 16.5% LOWER; announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>SeaChange Int'l (NASDAQ: SEAC) 14.3% HIGHER; Chairman, Robert Pons, bought 100,000 shares on 06/21 at $1.06.</p>\n<p>Bentley Systems, Incorporated (Nasdaq: BSY) 3.6% LOWER; announced that it intends to offer $500.0 million aggregate principal amount of convertible senior notes due 2027 (the Notes) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). Bentley also expects to grant the initial purchasers of the Notes a 13-day option to purchase up to an additional $75.0 million aggregate principal amount of Notes.</p>\n<p>WillScot <a href=\"https://laohu8.com/S/MINI\">Mobile Mini</a> Holdings Corp. (Nasdaq: WSC) 1.8% LOWER; announced the launch of an underwritten, secondary offering (the Offering) of 14,000,000 shares (the Shares) of its common stock, par value $0.0001 per share (the Common Stock). The Shares are being offered by the Companys principal shareholder, Sapphire Holding S.Ã r.l., an entity controlled by TDR Capital (the Selling Stockholder). The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 2,100,000 shares. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering.</p>\n<p><a href=\"https://laohu8.com/S/SHAK\">Shake Shack Inc</a>. (NYSE: SHAK) 1.5% HIGHER; SHAK and licensee Maxims Caterers Limited are continuing the momentum in China with an expanded partnership to open 10 Shacks in new territories by 2031, including locations in Sichuan, Chongqing, Yunnan, Hubei, Shaanxi, Anhui, Henan and Guizhou.</p>\n<p>Clean Energy Fuels (NASDAQ: CLNE) 1.5% HIGHER; disclosed that on June 21, 2022, the Company contributed $50 million to the bpJV and forced conversion of bp's Class B Units into Class A Units.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: (SEAC) (SHAK) (CLNE) Higher; (GMTX) (EYES) (BSY) Lower</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: (SEAC) (SHAK) (CLNE) Higher; (GMTX) (EYES) (BSY) Lower\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 07:32 GMT+8 <a href=https://www.streetinsider.com/dr/news.php?id=18591459><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nGemini Therapeutics, Inc. (Nasdaq: GMTX) 35.7% LOWER; announced initial data from its Phase 2a ReGAtta study of GEM103 as of May 2021 in patients with geographic atrophy (GA)...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18591459\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SEAC":"海易国际","BSY":"Bentley Systems, Inc.","CLNE":"Clean Energy Fuels Corp","SHAK":"Shake Shack Inc"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18591459","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145066030","content_text":"After-Hours Stock Movers:\nGemini Therapeutics, Inc. (Nasdaq: GMTX) 35.7% LOWER; announced initial data from its Phase 2a ReGAtta study of GEM103 as of May 2021 in patients with geographic atrophy (GA) secondary to dry AMD. ReGAtta is a dose escalation trial of GEM103, which is intravitreally administered recombinant human complement factor H (CFH), in dry AMD patients. The trial, which remains ongoing, is designed to evaluate safety and tolerability, as well as measures of intraocular pharmacokinetics (PK) and disease-relevant biomarkers, to inform the late-stage development program.\nSecond Sight Medical Products, Inc. (NASDAQ: EYES) 16.5% LOWER; announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nSeaChange Int'l (NASDAQ: SEAC) 14.3% HIGHER; Chairman, Robert Pons, bought 100,000 shares on 06/21 at $1.06.\nBentley Systems, Incorporated (Nasdaq: BSY) 3.6% LOWER; announced that it intends to offer $500.0 million aggregate principal amount of convertible senior notes due 2027 (the Notes) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act). Bentley also expects to grant the initial purchasers of the Notes a 13-day option to purchase up to an additional $75.0 million aggregate principal amount of Notes.\nWillScot Mobile Mini Holdings Corp. (Nasdaq: WSC) 1.8% LOWER; announced the launch of an underwritten, secondary offering (the Offering) of 14,000,000 shares (the Shares) of its common stock, par value $0.0001 per share (the Common Stock). The Shares are being offered by the Companys principal shareholder, Sapphire Holding S.Ã r.l., an entity controlled by TDR Capital (the Selling Stockholder). The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 2,100,000 shares. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering.\nShake Shack Inc. (NYSE: SHAK) 1.5% HIGHER; SHAK and licensee Maxims Caterers Limited are continuing the momentum in China with an expanded partnership to open 10 Shacks in new territories by 2031, including locations in Sichuan, Chongqing, Yunnan, Hubei, Shaanxi, Anhui, Henan and Guizhou.\nClean Energy Fuels (NASDAQ: CLNE) 1.5% HIGHER; disclosed that on June 21, 2022, the Company contributed $50 million to the bpJV and forced conversion of bp's Class B Units into Class A Units.","news_type":1,"symbols_score_info":{"BSY":0.9,"CLNE":0.9,"EYES":0.9,"GMTX":0.9,"SEAC":0.9,"SHAK":0.9}},"isVote":1,"tweetType":1,"viewCount":1880,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":36,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/123907470"}
精彩评论